VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,376 | -65.9% | 147,073 | -10.6% | 0.01% | -64.7% |
Q2 2023 | $4,033 | -1.6% | 164,483 | -6.6% | 0.02% | -5.6% |
Q1 2023 | $4,099 | +48.5% | 176,196 | +61.5% | 0.02% | +28.6% |
Q4 2022 | $2,760 | -99.9% | 109,093 | -45.3% | 0.01% | -33.3% |
Q3 2022 | $3,843,000 | +5.3% | 199,417 | +39.2% | 0.02% | +10.5% |
Q2 2022 | $3,648,000 | +1751.8% | 143,249 | +1756.0% | 0.02% | +1800.0% |
Q1 2022 | $197,000 | -1.5% | 7,718 | +65.8% | 0.00% | 0.0% |
Q3 2021 | $200,000 | – | 4,655 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |